Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Delirium 4Recurrence 2Neoplasm Metastasis 2Nausea 2Vomiting 1Neoplasms 1Haloperidol 1Glioblastoma 1Breast Neoplasms 1

Interventions

Dexamethasone 38Aprepitant 31Ondansetron 27Palonosetron 25Granisetron 16Calcium Dobesilate 15Olanzapine 12Therapeutics 8dexamethasone acetate 7Cyclophosphamide 7fosaprepitant 6casopitant 6Doxorubicin 6Radiotherapy 5netupitant 4dolasetron 4dexamethasone 21-phosphate 4Vincristine 4Tropisetron 4Metoclopramide 4Acupressure 4Yoga 3Psychiatric Rehabilitation 3Prochlorperazine 3Lorazepam 3Electroacupuncture 3Dronabinol 3Cisplatin 3Analgesia 3peppermint oil 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Nausea × Haloperidol × Clear all
NCT01556932 2015-10-16

Randomized Trial of the Effectiveness of Topical "ABH Gel" vs. Placebo in Cancer Patients With Nausea

Virginia Commonwealth University

Phase NA Completed
22 enrolled 7 charts

Nausea, Vomiting

NCT00124930 2012-01-19

Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer

AHS Cancer Control Alberta

Phase 3 Terminated
80 enrolled

Nausea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡